Showing posts with label Home Monitoring. Show all posts
Showing posts with label Home Monitoring. Show all posts

Monday, January 28, 2019

Article: Year of Telehealth

Here's an article telling us what lots of us already have learned, that telehealth is an up a coming method of providing effective and cost-effective as well as continuous medical care where ever a patient may be. Here's the link to the article: https://www.beckershospitalreview.com/telehealth/dr-toby-cosgrove-2019-will-be-the-year-of-telehealth.html

Here's a quote from the article that I think is of interest:

"[Oakland, Calif.-based Kaiser Permanente] is seeing over 50 percent of their patients distantly," Dr. Cosgrove told CNBC.

What Cosgrove isn't telling us is how telehealth is being provided. Telehealth is pretty loosely defined. It can mean that patients have access to a health care provider through chat or the telephone. Or it can mean something more sophisticated such as continuous medical-device communication and automated monitoring. One way or another telehealth is clearly on the rise and will likely become the standard for providing care.

Wednesday, November 28, 2018

Careband: Keeping track of those with dementia

I was at an evening venture capitalist meeting on 13 November 2018. I'm not a venture capitalist but I have a few connections to this community and I periodically receive invitations to their meetings. Most of the time I pass on attending. I'm interested in science, mathematics and technology. VCs are interested in ways to make money. Nothing against them. We just live on different planes of existence.

However, I attended this meeting because I read the description of one of the companies doing a presentation, careband (http:www.careband.co).

careband

Careband provides a capability to track the location of people with dementia. This is a more difficult problem than you might imagine. In institutions, patients with dementia are known to wander away: from the institution, from their homes, from family members. The patients do not know where they are or how to return. Institutions who care for dementia patients frequently need to find their patients who have wandered away from the institution's grounds or to areas of the institution that caregivers do not expect that they would be able to wander. 

Thus there's a clear need to be able to keep contact track of dementia patients. To know where their location at all times and be notified when they've wandered off the grounds of the institution.  Here's a page from the careband.co website that summarizes the capabilities of their system.


The diagram above shows the elements of system for patients and customers/caregivers -- those responsible for caring for the dementia patient(s). Caregivers can see at a glance the current location of each patient. Each dementia patient wears a band about the size of a large wristwatch on the wrist that periodically sends a location related message to the network. All data is sent to careband's cloud server system. Patient location data is made accessible to the caregiver systems that are connected to the cloud server system.

The wrist bands connect to the Internet to the low-power communications system: LoraWAN. More information about this wireless data communications network is available here: https://lora-alliance.org/about-lorawan The LoraWAN network is a low-power, low-speed (0.3 kbps to 50 kbps) but long distance (up to 3 miles from an access point outside) and robust wireless communications system. 

The wristband also includes Bluetooth that is used to provide indoor location data. And an accelerometer has been included to provide information regarding whether the patient has moved his or her body during the reporting period. 

I am not familiar with all of the current capabilities of the careband.co system. However, I know that the wristband continually transmits to the cloud the following data:
  • Patient ID data
  • Transmission time 
  • Location data
  • Movement (whether or not the person has moved from the time of the last data transmission and the time of the current data transmission)
  • Battery charge level
How careband.co is currently analyzing is something of which I am presently unsure, but there are a number of pieces of information that can be derived from this relatively small amount of data. Here's what's possible:

  1. Current patient location
  2. Map of patient's activity and the distance covered over time
  3. Amount of time that the patient was moving
  4. Alarm initiation: should the patient stray away from the institution, the system can automatically notify the caregivers. (Boundaries should be able to be drawn on the display.)
  5. Trend and trend line analysis for patient activity time and distance covered. These could be indicators of the patient's cognitive health. Significant deviations from calculated trend lines could be indicators of a slip or improvement in a patient's cognitive and/or physical health.
  6. Suggest that the patient has removed the band from his or her wrist (when the patient appears not to have moved during normal activity time) or that the patient maybe in distress or died.
There could be more information that can derived from the wristband data that I have yet to think of. As I come up with additional thoughts regarding this, I shall post them.

Upgrades to the wristband could include pulse oximetry and pulse rate data. Again, there are other capabilities that could be added that I have yet to think of.

Since the transmission speed is so low, careband.co will likely need to develop a data compression system to effectively communicate this data back to the cloud server system. 

Careband.co is one more interesting product for remote medical monitoring. It's not designed for remote patient management largely because most patients will normally be closely supervised. However, it could be an aid to enable people with dementia to live for a longer time in their own homes. The benefits to both the patient and to society are massive. Six months to a few years of being able to live in one's own home would improve both the quality of life for people with dementia and significantly, dramatically reduce the cost of care.

I shall continue to monitor careband.co's progress. Stay tuned.

Careband.co plans on making their products available through medical device distributors. Their products are not yet commercially available. They are about to manufacture the wristband. Their wristband has been approved by the FCC. FDA approval is not required.  If you are interested in purchasing their product, please contact them at care band.co.

I should mention that careband.co is looking for investors. If you're interested in what careband.co is selling, please contact them directly using the URL listed above.

Wednesday, August 8, 2018

Measuring cortisol — the stress hormone, remotely

Having the ability to remotely and continuously measure the level of a stress-related hormone would seem to be something of real value.

A new wearable biosensor, developed by the Salleo lab at Stanford, measures the amount of cortisol in a person’s sweat. 

Here is the link to the announcement/article: https://www.medicaldesignbriefs.com/component/content/article/mdb/insider/32762?utm_source=TBnewsletter&utm_medium=Email&utm_campaign=20180808_Medical_Newsletter&eid=376600177&bid=2199287

Monday, August 6, 2018

FCC approves telemedicine pilot for veterans, low-income, rural Americans

I'm actually surprised that this trial had not been approved earlier. Here is the announcement from the FCC.

 This is a link to an article that provide more detail on this program.

https://www.mobihealthnews.com/content/fcc-approves-telemedicine-pilot-veterans-low-income-
rural-americans?mkt_tok=eyJpIjoiT1dJNVl6UmxaVFExT1RkaCIsInQiOiJrb1B5Y0drbTRBMzRoMHFcLzBpUlpCTVljT1lBUGhhcUNCazA2RndKOW8zXC94dTFVSU5ua1VYY1NzeHBQazRsYW5hMkdsaTRETndXb01CTDZjN1Zva2VRYmRIUElic0FCc21BYVowSWdFTGVtTSt1Y2kxTXFGSHRuYlNCcitSRU5TIn0%3D

Since this is a pilot program, data should be collected about it's effectiveness. This is something that those who are interested in medical remote monitoring and remote patient management should be interested in following. I know I will.




Monday, July 30, 2018

Apple Watch 4: Will it be suitable as a remote medical monitoring device? Part 1

When I first commented about the Apple Watch as being a possible platform for a remote medical monitoring system in 2015, I was initially excited about the possibilities. Sadly, the technology in 2015 was not quite ready as a platform for remote medical monitoring systems. However, Apple may be turning a corner with the Apple Watch 4 due to be released in Fall 2018. 

To be an effective remote medical monitoring and remote patient management device, the Apple Watch will need to reach acceptable levels of performance in the following seven areas of concern:

  1. Bio-sensors
    • Built in: are there enough bio sensors with enough resolution?
    • Extended: the capability to have additional bio sensors that communicate wirelessly with the watch?
  2. Communications over the Internet: Is there a reliable and secure means of communication back to the patient's monitoring system? And the means to communicate with the patient over that same communications channel(s)? 
  3. Processing capability, hardware and software: Does the watch have the processing capability to host medical applications?
  4. User interface: Visual, touch screen - will patients be able to interact with medical application using the touch screen? Will the watch have an effective audio user interface in order to hear instructions and make requests of the application running on the watch?
  5. Reliability: Will the hardware and software reliable enough for a remote medical monitoring and patient management application to run on it?
  6. Battery life: When running a remote medical monitoring and patient management application(s) on the watch, will the battery life before needing to recharge be acceptable?
  7. Rugged: Is the Apple Watch 4 rugged enough to be a remote medical monitoring and patient management device?
I'm going to touch on each of the areas of concern regarding the performance of the Apple Watch 4.

  1. Bio-sensors: I'm not going to address this issue until the Apple Watch 4 has been released. Once it has been released, I'll write an article specifically discussing this topic.
  2. Communications over the Internet: A model of the Apple Watch 3 does have the capability of communicating over 4G so reliable communication over the commercial wireless provider networks is possible. We can assume that this capability will continue to the next release. So communications capabilities are likely to be adequate. 
  3. Processing capability, hardware and software: Improvements in both are promised over the Apple Watch 3. We can probably assume that hardware and software capabilities will be adequate.
  4. User interface:
    • Visual, touch screen: The Apple Watch screen has been targeted to those with good visual acuity (with or without glasses) and fine finger control to be able to use the touch screen effectively. Current reports say that the screen will be larger than the Apple Watch 3. Nevertheless it's still a small screen. 
    • Auditory: The Apple Watch 3 has Siri, meaning it does have an auditory user interface. More on this after the release of Watch 4.
  5. Reliability: Apple has made positive strides in reliability with each release of the Apple Watch. We can assume that this will continue and that the Apple Watch 4 will be reliable enough to serve as a platform for remote medical monitoring and remote patient management applications.
  6. Battery life: The Apple Watch 3 has a reported battery life of up to 18 hours. Again Apple has continued its improvements in this area. Patient medical monitoring should be continuous and without long breaks. Even with one or more days of battery life, the watch will still need to be changed and that could take hours. However, having said that, the price of an Apple Watch (because of the ruggedness requirement) that would serve as a remote medical monitoring and patient management device would be around $600. As medical devices go, that's inexpensive and inexpensive enough so that the patient could or should have at least two Apple Watches that would enable the patient to switch watches when necessary. That would place a burden on application software developers to manage when patients change watches, however, this should be manageable.
  7. Rugged: The Apple Watch 3 has a version in a stainless steel case. This should be adequate for most situations. Also the issue of reasonably low price and the ability to have redundant watches should effectively address this issue.

Tuesday, July 24, 2018

Adhesives: Part of the Future for the Remote Monitoring Sensors?

I just ran across this article a few minutes ago. It's a serious article published in Machine Design. Here's the link: http://www.machinedesign.com/mechanical/adhesives-enabling-future-wearable-medical-devices?NL=MD-005&Issue=MD-005_20180724_MD-005_524&sfvc4enews=42&cl=article_1_b&utm_rid=CPG05000003255032&utm_campaign=18775&utm_medium=email&elq2=5b76b40ea8f44d76b2b883c5c09f23fe

It's an extremely readable article and what's being described has in my opinion real applicability in the future of medical sensors. Adhesive, "band-aid" or strip sensors development applies to both the fitness set as well as to remotely monitored patients.

Transmitting data to monitoring systems and people will likely require an intermediate device such as a smart phone. I suspect that the real issues and hurdles will likely revolve around digital communications issues and standardization. Having worked most of my life in the communications domain, communications issues can be successfully overcome.

Here are a few quotes from the article:

Device manufacturers are taking steps to create medical devices that are smaller, lighter, and less invasive. Whether they’re adhering device components together or sticking a device to skin, adhesives are uniquely bonded to a device’s success.

Both consumers and patients want wearable devices to be smaller, lighter and less cumbersome to use for seamless integration into their everyday lives. The design process can get challenging when devices must maintain accurate sensing capabilities, but also reduce friction to ensure precise data collection. Adhesives can help to keep friction to a minimum by being breathable and maintaining a low profile. In addition, options with flex electronics, as well as addressing battery implications and electromagnetic interference, provide opportunities for advancement.

Adhesive wear time is a crucial consideration when designing a wearable device, impacting overall resilience and durability, as well as how often the user will need to change their device. 

______________

I should mention that by the looks of things, it appears to me that 3M maybe behind the article. Nevertheless, I think that considering adhesives in the research, design and development process of a bio-sensor is worth your time. 


Sunday, July 22, 2018

Article: Remote Monitoring of Heart Failure Patients

Although this article was published in 2013, it's findings are still applicable today. Moreover, there is applicability of this system remote monitoring and remote patient management to patients with other chronic conditions other than heart failure. 

I have experience with engineering methods to support remote monitoring and treatment of heart failure patients and this article is an extensive review many of the systems that were and would be coming available in 2013 and later.

Here is the link: Remote Monitoring of Heart Failure Patients by Arvind Bhimaraj, M.D., M.P.H. I recommend this article if you have an interest in many of the details of remote monitoring and remote patient management.

Heart Failure


Heart failure is a chronic disorder and requires continual monitoring and management. The management of heart failure patients remotely can serve as a model for managing patients with other chronic disorders such as diabetes or COPD.

Article Abstract (from the article)

Heart failure continues to be a major burden on our health care system. As the number of patients with heart failure increases, the cost of hospitalization alone is contributing significantly to the overall cost of this disease. Readmission rate and hospital length of stay are emerging as quality markers of heart failure care along with reimbursement policies that force hospitals to optimize these outcomes. Apart from maintaining quality assurance, the disease process of heart failure per-se requires demanding and close attention to vitals, diet, and medication compliance to prevent acute decompensation episodes. Remote patient monitoring is morphing into a key disease management strategy to optimize care for heart failure. Innovative implantable technologies to monitor intracardiac hemodynamics also are evolving, which potentially could offer better and substantial parameters to monitor.

My Analysis

With the advent of smartphones and increasingly sophisticated, smaller and lower power bio-sensors, remote monitoring and remote patient management of all types of chronic conditions should be on the rise. Furthermore, the rise and acceptance of computerize expert medical systems (artificial intelligence), should make remote monitoring and remote patient management a first choice. Not only will this lower costs, but as we have seen it: increases patient satisfaction and mobility, enabling a patient to spend time traveling and enjoying the life that remains.

One more thing ... and I have to add this as a point of pride, a quote from the article:

Also, advancements in implantable wireless technology seen with the pulmonary capillary pressure monitoring device CardioMEMS® (CardioMEMS, Inc., Atlanta, GA) and the left atrial pressure monitor HeartPOD System (St. Jude Medical, Inc., St. Paul, MN) or Promote® LAP System (St. Jude Medical, Inc., St. Paul, MN) bring us closer to finding the holy grail of home monitoring systems. (my emphasis)

I had a part in SJM's LAP project. I was working at SJM when this project was in the state of early patient trial. The project manager needed assistance with issues related to and testing of operation of the user interface including the how the computerize system would interact with patients to collect necessary data and provide the patient with directions on what to do to manage their current condition -- mostly, taking medication and performing certain activities. I provided that assistance, design direction and usability testing for this early stage product. Although I haven't seen this system in it's commercial form, I suspect that a lot of what I did was included in the commercial product. The "holy grail" comment is personally gratifying. And I should mention that my experience with the LAP system was one of this things that lead me to starting and continuing with this blog.


Wednesday, March 25, 2015

New York Times Opinion: Why Health Care Tech Is Still So Bad

This was an opinion piece published 21 March 2015 in the New York Times written by Robert M. Wachter, Professor of Medicine, University of California, San Francisco and author of "The Digital Doctor: Hope, Hype, and Harm at the Dawn of Medicine’s Computer Age” also published in the New York Times.

Here's the link to the article: http://www.nytimes.com/2015/03/22/opinion/sunday/why-health-care-tech-is-still-so-bad.html?smid=nytcore-ipad-share&smprod=nytcore-ipad

I have commented on several quotes from the article.

1. "Even in preventing medical mistakes — a central rationale for computerization — technology has let us down. (My emphasis.) A recent study of more than one million medication errors reported to a national database between 2003 and 2010 found that 6 percent were related to the computerized prescribing system.

At my own hospital, in 2013 we gave a teenager a 39-fold overdose of a common antibiotic. The initial glitch was innocent enough: A doctor failed to recognize that a screen was set on “milligrams per kilogram” rather than just “milligrams.” But the jaw-dropping part of the error involved alerts that were ignored by both physician and pharmacist. The error caused a grand mal seizure that sent the boy to the I.C.U. and nearly killed him.

How could they do such a thing? It’s because providers receive tens of thousands of such alerts each month, a vast majority of them false alarms. (My emphasis.) In one month, the electronic monitors in our five intensive care units, which track things like heart rate and oxygen level, produced more than 2.5 million alerts. It’s little wonder that health care providers have grown numb to them."

Comments: Before I read the third paragraph, I was thinking How can you blame the computer when it provided you with an alert regarding the prescribing error that you made? 

It is well known that systems that produce a high percentage of false alarms, that those alarms over time will be ignored or discounted. I consider this is a devastating indictment. We must do better.

I have been a human factors engineer and researcher for decades. One of the mantras of human factors is preventing errors. That's central to what we're about. But if the systems we help engineer generate false alarms at a rate that has our users ignoring the correct ones, then we have failed and failed miserably.

I think the problem of false alarms requires further research and commentary.


2. "... despite the problems, the evidence shows that care is better and safer with computers than without them."

Commentary: This is nice to read, but we as medical technologists need to do better. We really need to follow up on the repercussions of our technology we create when it's deployed and used in the field.


3. "Moreover, the digitization of health care promises, eventually, to be transformative. Patients who today sit in hospital beds will one day receive telemedicine-enabled care in their homes and workplaces."

Commentary: I agree. Of course that's a central theme of this blog.


4. "Big-data techniques will guide the treatment of individual patients, as well as the best ways to organize our systems of care. ... Some improvements will come with refinement of the software. Today’s health care technology has that Version 1.0 feel, and it is sure to get better.

... training students and physicians to focus on the patient despite the demands of the computers.

We also need far better collaboration between academic researchers and software developers to weed out bugs and reimagine how our work can be accomplished in a digital environment."

Commentary: Agreed again. But, I believe that technologist just can't dump these systems into the healthcare environments without significant follow-up research to insure that these systems provide or suggest the correct treatment programs and effectively monitor patients. Investment in systems like these will be cost effective and improve lives, but only if the necessary level of care and follow-up is performed.


5. "... Boeing’s top cockpit designers, who wouldn’t dream of green-lighting a new plane until they had spent thousands of hours watching pilots in simulators and on test flights. This principle of user-centered design is part of aviation’s DNA, yet has been woefully lacking in health care software design."

Commentary: All this is true. And as noted above that it would be a good idea to do more extensive research on medical systems before we deploy them to the field as well. That this is not done may be a regulatory issue that the FDA has not required the kind of rigorous research as performed in aircraft cockpit design. They should require more research in real or simulated environments. Right now, all that appears to be required is a single verification and single validation test before allowing commercialization. I think it would be valuable for regulators to require more research in real or simulated settings before allowing companies to commercialize their products.

Or, requiring more extensive follow-up research. Grant companies the right to sell their medical products on a probationary basis for (say) 1 year after receiving initial commercialization certification. During that year, the company must perform follow-up research on how their medical product performs in real environments. If there are no significant problems ... such as overly abundant number of false alarms ... then the product no longer on probation and would be considered fully certified for commercialization.
However, if significant problems emerge, the FDA could:

a) continue to keep the product in a probationary status pending correction of those problems and another year of follow-up research or

b) it could require the withdrawal of the product from sale. A product that had been withdrawn would have to go through the entire commercialization certification process just as if it were a new product before commercialization and sale would be allowed.


A final thought ... I think there's a reality in commercial aviation that is not true in medicine. If commercial aircraft killed and injured as many people as are killed and injured by medical practitioners, then the commercial aviation would come to a halt. People would refuse to fly because they perceive it to be too dangerous. But, if you're sick, then you have little choice but the clinic, ER or hospital.







Tuesday, March 24, 2015

Internet of Things ... From a Connected Medical Device Perspective

Before I dive into the issues regarding the possible means for connecting medical devices to the Internet, I would like to provide you with a little background on two relevant research programs I have lead. I was the principal investigator on two Federally supported research programs described below.

The first was a NIST Research grant to support the development of a secure and commercially viable wireless data communications technology. Much of that technology has been incorporated into today's smartphones, although not all of what we created has yet found its way into the current generation of smartphones. But with each iteration, more of what we created gets incorporated.

A central part of our program was to insure secure and private data communications. It would be secure from infiltration by malware and impenetrable by snoops ... including the NSA. The system worked by securing and controlling both ends of the communication. It was capable of sending a single file to over multiple communications channels simultaneously, the packets could be sent out of order using multiple forms of encryption including nonstandard or private encryption methods -- that are much harder to break. By securing and controlling both ends of the connection between devices, we could completely control what went in and out of the channel. Nothing would flow to the other end that was out of our view or control.

The second Federal grant was for a data security program. VoIP communications channels are lightly secured largely due to the requirements to insure that audio is clear and voices understandable. This fact makes VoIP channels particularly vulnerable vectors to use for an attack. There have been attempts to logically divide voice and data channels; however, there have been several demonstrations that this does not always work. Our research focused on methods to detect the presence of an intruder without disrupting or significantly lowering audio quality. And when we detected a possible intruder, we attacked this apparent intruder through a series of escalating techniques that could finally end with terminating the connection when it was clearly apparent that an intruder was using the VoIP connection to do something nefarious.

Architectures for the Internet of Things

The two architectures I would like to review are direct and mediated connections that could be used in the realm of the Internet of Things.

Direct and mediated connections are illustrated in the figure below.


The real difference between the two diagrams is the way the Apple Watch is connected to the Internet. On the left the Watch is directly connected to the Internet. When connected, it is an addressable device on the Internet. On the right, the Watch is connected to the Internet through the iPhone. The iPhone mediates the connection to the Internet through the iPhone. All the data traffic to and from the Watch goes through the iPhone.

A mediated connection through the device can be as simple and unmanaged as one through a router. However, with the appropriate software on the iPhone, the iPhone should be able to manage the connection with and security of the Watch.

In the case of the direct connection, management of the connection to the Internet including security must be done by the Watch itself. The Watch could be subject to a direct attack and must defend against such an attack by itself.

Best Architecture for Medical Devices?

In the diagram above, I'm treating the Watch as if it were a medical device ... and a medical device it could be. It would seem that the safest connection to the Internet would be a mediated connection. However, there are hybrid scenarios. For example, incoming communications including software updates could require a mediated connection. Encrypted uploads from the Watch to a centralized server system could use a direct connection.

This is a brief introduction into this topic. I'll have further explorations into this issue in future articles.

Sunday, July 18, 2010

Gadgets of the Future

An interesting and to some degree a light-hearted article about future systems that could monitor us.  This was published in the Chicago Tribune.


Here's the link: http://www.blogger.com/post-create.g?blogID=1944904461287889974

Tuesday, May 4, 2010

Medical Design Article: FDA announces Medical Device Home use Initiative

As I was working on a human factors related article, this article from Medical Design appeared.  Here's the link to the article: http://medicaldesign.com/contract-manufacturing/fda-announces-medical-device-home-050310/

I thought that this article is interesting and telling with respect to how the FDA will assert it regulatory authority regarding usability issues. Here are a few quote from the article.

Recognizing that more patients of all ages are being discharged from hospitals to continue their medical treatment at home, the U.S. Food and Drug Administration announced an initiative to ensure that caregivers and patients safely use complex medical devices in the home. (My emphasis.) The initiative will develop guidance for manufacturers that intend to market such devices for home use, provide for post-market surveillance, and put in place other measures to encourage safe use of these products. The FDA is also developing education materials on home use of medical devices.
These home care patients often need medical devices and equipment such as hemodialysis equipment to treat kidney failure, wound therapy care, intravenous therapy devices, and ventilators. 

Friday, April 23, 2010

Medical Implant Issues: Part 1, A True Story

When I started this article, I thought I could place it into a single posting.  However, having written just the first section, noted it's length and how much more there was to write.  Thus, I decided to turn this into a serialized publication just as I am doing with HE-75.  Thus, here is Part 1 ...
 

Part 1: Background Story

Before I dive into the technical details of this issue, I want to tell a true story from my own experience.  It involves a friend of mine.  (I need to be vague regarding the person's identity including gender and how I came to know this person.  As you read this, you'll understand.

My friend was incredibly intelligent (e. g., the best applied statistician I have ever known) and physically attractive, and diagnosed as a paranoid schizophrenic.  In the early 1990's, my friend underwent back surgery.  To my amazement, my friend claimed that the surgeon had placed a "chip," small processor into the person's spinal cord.  My friend said that the chip could be activated by people with controls that looked like garage door openers.  When activated, the chip would cause my friend to have a sudden, overwhelming desire to have sexual relations with the person who had activated the chip.  My friend called this chip a "tutu."

At the time I had been part of the cutting-edge technology community to know that such a chip was absurd.  And I told my friend that this chip did not exist. My information was not well received by my friend who was convinced of the reality of this chip.

I tell this story because at the time my friend informed me of the "tutu," the idea of embedding a chip in a human being and activate it using wireless means was patently absurd.  Embedding programmable chips with wireless communications less than a decade and a half later is no longer considered absurd, but real.  And for some people, frightening with religious overtones.  Consider what the Georgia state legislature just passed and you'll understand what I mean.  Here's a link to that article: Georgia Senate Makes "Mark of the Beast Illegal."


The reaction from the Georgia Senate makes my paranoid-schizophrenic friend's story seem plausible.  Interestingly enough and I did not realize it at the time (but I do now), that was my introduction to wireless, medical remote programming.  As I said, my friend was extremely intelligent and as it turned out more creative and prescient than I realized at the time.  Turns out that today a device embedded in the spinal cord with the ability to trigger sexual experience is real.  And the ability to embed microprocessors and controls in people with the capability of wireless communication and medical management is also real.


I tell you that story not to make light of people's stories and fears, but as a "sideways" introduction to the technical topic of dealing with multiple, embedded medical monitoring and remote programming systems.  And to suggest that people may have real fears and concerns regarding the capabilities that technologists like myself often overlook.  In this series I discuss real and imagined fears as well as the technical problems with multiple, implanted devices.




Part 2: Multiple, Implanted Wireless Communicating Devices






Books sold by Amazon that might be of interest in this series

New Frontiers in Medical Device Technology

MEMS and Nanotechnology-Based Sensors and Devices for Communications, Medical and Aerospace Applications
 

Monday, April 19, 2010

Market Research Report Available: Remote & Wireless Patient Monitoring Markets

A new market research report has just been made available that discusses the market and investment potential of remote and wireless monitoring of patients.  I do not endorse this study or suggest it's purchase.  I am making it's existence known.

Here's a list of some of disorders covered by the study:
  • Asthma
  • COPD
  • CHF
  • CHD 
  • Diabetes 
Here are a few quotes from the press release:


Patient monitoring systems are emerging in response to increased healthcare needs of an aging population, new wireless technologies, better video and monitoring technologies, decreasing healthcare resources, an emphasis on reducing hospital days, and proven cost-effectiveness.
Of these new high-tech patient monitoring systems, nearly all focus on some form of wireless or remote patient monitoring. ...
...  the following companies are profiled in detail in this report:
  • Abbott Laboratories, Inc
  • Aerotel Medical Systems
  • GE Healthcare
  • Honeywell HomMed LLC
  • Intel Corporation
  • Philips Medical Systems
  • Roche Diagnostics Corporation

Here's the link to the press release and links to purchasing this study: http://www.marketresearch.com/product/display.asp?productid=2645944&g=1

 

Friday, April 9, 2010

Article: Wireless Remote Monitoring Prevents Complications of Chronic Diseases

An interesting article about the benefits of remote monitoring in the care of patients with chronic diseases from the Press of Atlantic City, 8 March 2010.  Here's the link to the article:  http://www.pressofatlanticcity.com/life/monday_health/article_1333e585-e3a6-5ba8-a411-75530f6b63cf.html

Quotes from the article:
Improving management
By early 2012, Americans will use about 15 million wireless health-monitoring devices, according to a forecast from ABI Research, which tracks mobile-technology trends. The mobile health market is projected to more than triple to $9.6 billion in 2012 from $2.7 billion in 2007, according to study from Kalorama Information Inc
[T]he first pilot project in the nation to assess whether the use of remote digital devices with data sent over the Internet to a doctor's office improved management of multiple chronic diseases - diabetes, heart disease and high blood pressure, also known as hypertension. 
Diabetics and hypertensive patients increased the number of days between appointments by 71 percent and 26 percent respectively ...
"One of the great promises of wireless (health) is making it a part of the patient's daily life, not an interruption to what they're doing every day," ...
From personal experience I believe the last sentence I quoted is among the most important in the article.  The entire process should be so smooth, so automated, so uncomplicated and unintrusive that the patient's life is uninterrupted and that the data is seamlessly collected and sent to the patient's caregiver.

Two other items to note.  The first is a brief discussion of the sensors connected to the patient's body.  They mention band-aid size electrodes.  I am not sure if these are the "digital plaster" that I've discussed in an earlier article.  http://medicalremoteprogramming.blogspot.com/2009/11/digital-plaster.html
Or something else.  I do not know, but it would be interesting to find out.  If I have any informational, I'll post it.  If you have any information, please enlighten us with a comment.

The second issue of note is the discussion in the article regarding payment, and who will do it.  Given the convoluted nature of our system of payments, this will be the most difficult issue to resolve, I believe.  It's ironic considering that remote monitoring saves money.   I think the technical issues will be minor in comparison.  I hope I am proved wrong.

Remote Monitoring/Programming and Diabetes Management

Diabetes management is a personal area of concern for me.  No, I'm not diabetic.  However, my late mother-in-law was.  She had Type II diabetes; however, she was not overweight.  She died of a sudden cardiac arrest that was a direct result of her diabetes.  Although she did a great deal to manage her diabetes, her insulin would swing widely.  Those wide swings damaged her heart muscles leading to a cardiac arrest.  I can't help but believe if remote monitoring had been available to her, that she should would be alive today.

In the past my primary topical area has been cardiac rhythm management.  I plan to broaden my focus. Diabetes management using remote monitoring and even remote programming will be a topical area of increasing focus in this blog.  In later weeks I plan to branch out into COPD.

For those of you who have domain expertise in diabetes management and COPD, I would appreciate your comments.  You can make your comments in the comment area of this blog or email them to me.  Whatever way you feel the most comfortable.

To get things started, I have three links that I would like share.  The first link is a blog article titled, "Finding patterns in diabetes treatment may be key for telemedicine."  The article is a brief discussion about a presentation by Dr. David Klonoff of Mills-Peninsula Health Center and UC San Francisco.  His focus was on Type I diabetics, however, I believe what he discussed has significant implications for Type II diabetics as well.  Dr. Klonoff's interest is technology "...for automatic measurement of blood glucose, automatic dose calculation, and automatic insulin delivery."  From the article ...
For this ideal scenario to develop, five technologies need to be solved, and Klonoff sees printed electronics being used in every one:
  • Self-monitoring of blood glucose
  • Continuous (and ultimately non-invasive) monitoring of blood glucose
  • Alternate routes for delivering insulin rather than needles, such as micro-needles. (Klonoff referred to work being done at UC Berkeley; I saw some demonstrated at the University College Cork/Ireland (PDF poster here) although using traditional semiconductors, not printed electronics.)
  • Artificial pancreas
  • Telemedicine
 In the quotation above, there are several links.  The one of greatest interest to me and to this forum, is the "non-invasive" link.  This will link you to an article titled, "The Search for Noninvasive Glucose Technology That Works: Where It Stands Now".


The article is a discussion of a need for a means for non-invasive monitoring of glucose levels.  The capability of having a non-invasive means of monitoring glucose levels would go a long ways towards supporting automatic, remote monitoring of glucose levels.  This could be an extension of the body area networks work (BANs).  So if anyone has any ideas in this area, apparently this is a wide open area for invention.

Finally, I want to provide a link to a brief report by the Whittier Institute of Diabetes.  The report is undated, but a brief review of the document's properties indicated that it was created in 2004.  It's not as recent as I would like, however, I believe that it's findings are relevant.  In summary, it showed that even relatively crude means for monitoring diabetes could lead to some positive outcomes at relatively low cost. 

 

Tuesday, March 30, 2010

How to Hack Grandpa's ICD

I've discussed possible communications security problems with implanted devices in an earlier post.  The link below provides a link to a University of Washington study that was published in 2008 in IEEE Symposium on Security and Privacy. Here's a link to the University of Washington article. 

Researchers find implantable cardiac defibrillators may expose patients to security and privacy risks


The article includes a link to the published paper.  I suggest that you download the paper and read it. 


Although the article was published in 2008, I believe it still has relevance.  First, it references a Medtronic Carelink Home Monitoring unit that I am quite certain is still in widespread use.  Second, they reverse engineered the Medtronic unit to create their own system that could mimic the Medtronic unit.  Although I am not an electrical engineer by any stretch of the imagination, I can attest to soundness of their methods.  I have worked with a variety of engineers who have tested communications system security using similar methods.  Furthermore, I have worked with engineers who have successfully cracked harden communications systems.  Thus I shall continue to monitor developments and findings in this field because this could impact the engineering of the communications systems for remote monitoring and programming.


One of the flaws in the Medtronic unit that made reverse engineering relatively easy was that the data was not encrypted.  I do not know if currently any or all communications between home monitoring units from any device company and implanted devices is encrypted.  Encryption adds significant overhead to communications.  Thus it makes the communication between the device and a home monitoring unit significantly longer.  It can impact battery life because encrypted transmissions have more bytes to transmit.

One of the potential limitations to hacking implant radio communications is the extremely low power level of that communication. The low power levels suggest that the hacker would have to be in close proximity to the device, within three meters.  However, their article did not extensively investigate the communications distance issue or methods that might be used to get around the proximity problem.

Third, the authors also had access to a Medtronic programmer.  A study of the operations of the programmer enable the authors extend their capabilities to hack communications with the implanted device. 

The scariest part of the article is a discussion of how it would be possible to kill a person with an ICD using the device they constructed.  Here's that section of the article (edited):

Inducing fibrillation

During implantation surgery, it is common for a physician to test the newly implanted ICD to ensure that it can both sense and appropriately treat a cardiac
condition known as ventricular fibrillation (V-Fib), one of the most common kinds of heart rhythm problems.
Accordingly, the ICD has several testing modes in which it can induce VFib.  Such a test — called an electrophysiological (EP) study — is normally conducted with cardiologists standing by to stop the fibrillation if the ICD fails to do so. ... [a] programmer sends the ICD a sequence of commands that ... [a] shock to be applied to the patient’s heart at a precise point in the patient’s cardiac rhythm, with the goal of inducing V-Fib. When its automatic therapies are enabled, the ICD should immediately detect and treat the fibrillation by delivering the proper therapy. ... We then used our commercial programmer to conduct an EP study ... We then replayed a recording of the EP study command sequence via our software radio. At least three of 30 replay attempts succeeded. We successfully triggered command shocks via replayed commands even after turning off all of the
ICD’s automatic therapies.

Quoted from:
Halperin, D, Heydt-Benjamin, T., Ransford, B., Clark, S., Defend, B., Morgan, W., Fu, K., Kohno, T., Maisel, W. Pacemakers and Implantable Cardiac Defibrillators:
Software Radio Attacks and Zero-Power Defenses, IEEE Symposium on Security and Privacy,
2008, pp 1-14.

Wednesday, October 28, 2009

Biotronik Home Monitoring Claim

I'm posting this article before my discussion on measurement and sensing because it has relevance to my immediately preceding posting.  

Biotronik released to the press on Tuesday 27 October 2009 an announcement regarding their Evia Pacemaker.  In that press release was some additional information regarding Biotronik's Home Monitoring system.  Here's the link to the press release: http://www.earthtimes.org/articles/show/biotronik-launches-evia-pacemaker-series,1016041.shtml

The relevant quote from the press release is the following:

Now physicians have the choice to call in their patients to the clinic or perform remote follow-ups with complete access to all pertinent patient and device information, including high quality IEGM Online HD®. Importantly, BIOTRONIK Home Monitoring® has also received FDA and CE Mark approval for its early detection monitoring technology which allows clinicians to access their patients’ clinically relevant event data more quickly so they can make immediate therapy decisions to improve patient care. 


The indications are that the Biotronik claims that their system provides quicker access to relevant data, not that the data (and analysis) yield earlier warning results.  This is consistent with my earlier analysis and that seems to be supported by Biotronik's own admission.

I do wonder about Biotronik's long-term objective.  I suspect that Biotronik wants to be one of the big three implantable device manufacturers, not just become one of four.  It would mean that Biotronik would likely target one of the big three to replace and that would likely involve targeting the weaknesses of the company that Biotronik wants to replace.  I'll continue to monitor Biotronik and report what I find.



Next, my discussion on measurement and detection.